Session Details

Oral Presentation 4 : Basic virology

Sat. Sep 27, 2025 10:55 AM - 11:45 AM JST
Sat. Sep 27, 2025 1:55 AM - 2:45 AM UTC
Room 5(2F Meeting Room 204)
Chair:Tsutomu Kageyama, Kazuya Shirato

[O4-01]ヒト呼吸器上皮細胞の気液界面培養系を用いた呼吸器ウイルスの感染ポテンシャルの評価

Miyuki Kawase1, Satoko Sugimoto1, Masatoshi Kakizaki1, Yohei Kume2, Hisao Okabe2, Sakurako Norito2, Makoto Ujike3, Hayato Go2, Mitsuaki Hosoya2, Koichi Hashimoto2, *Kazuya Shirato1 (1. Japan Institute for Health Security, National Institute of Infectious Diseases, 2. Fukushima Medical University, 3. Nippon Veterinary and Life Science University)

[O4-02]SARS-CoV-2感染ハムスターにおけるシクロスポリンAおよびマニジピンの重症化抑制効果

Moe Kobayashi1, Nene Kobayashi1, Seira Omori1, Sumire Ito1, Sara Omori1, Kurumi Miyaoka1, Yua Matsumoto1, Yasuhiro Yamada2, *Takeshi Ichinohe1 (1. The Institute of Medical Science, The University of Tokyo, 2. Department of Molecular Pathology, Graduate School of Medicine, The University of Tokyo,)

[O4-03]弱毒麻疹ワクチン田辺株をベースとした麻疹ウイルスベクターの構築

*Kotaro ISHIDA1,2, Kaoru YAMANO1,2, Naoya SHIRAISHI1,2, Takeshi SUGIMOTO1,2, Yasuyuki GOMI2, Hirotaka EBINA1,2 (1. Virus Vaccine Group, BIKEN Innovative Vaccine Research Alliance Laboratories, Research Institute for Microbial Diseases, University of Osaka, 2. The Research Foundation for Microbial Diseases of Osaka University)

[O4-04]外来遺伝子を発現する光制御可能な組換え牛パラインフルエンザウイルス3型の作出

*Takashi OKURA1, Maino TAHARA1, Noriyuki Otsuki1, Moritoshi SATO2,3, Kaoru Takeuchi4, Makoto TAKEDA5 (1. National Institute of Infectious Diseases, 2. GraduateSchool of Arts and Sciences, The University of Tokyo, 3. Kanagawa Institute ofIndustrial Science and Technology, 4. Tokiwa-Bio inc., 5. Graduate School of Medicine andFaculty of Medicine, The University of Tokyo)

[O4-05]Multifaceted dual-target antiviral activity of sparfloxacin suppresses respiratory syncytial virus replication in vitro and in vivo.

*Noriko Ogasawara1,2, Soh Yamamoto1, Yuka Tanimukai2,6, Yurie Yoshida2,1, Akihiko Sato3,4,5, Hirofumi Sawa4,5, Yasuko Orba4,5, Keitaro Yoshida1, Kenichi Takano2, Shin-ichi Yokota1 (1. Division of Microbiology, Department of Infectious Diseases, Sapporo Medical University School of Medicine, 2. Department of Otolaryngology-Head and Neck Surgery, Sapporo Medical University School of Medicine, 3. Laboratory for Drug Discovery & Disease Research, Shionogi & Co., Ltd., 4. International Institute for Zoonosis Control, Hokkaido University, 5. Institute for Vaccine Research and Development, Hokkaido University, 6. Department of Otolaryngology, Obihiro Kosei Hospital)